Biomarkers to help guide management of patients with pulmonary nodules

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 4, 2013, Pages 461-465

  Patz Jr , Edward F ^a   Campa, Michael J ^a   Gottlin, Elizabeth B ^a   Trotter, Priscilla R ^a   Herndon II, James E ^a   Kafader , Don ^b   Grant, Russell P ^b   Eisenberg, Marcia ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

Biomarkers; Diagnosis; Lung cancer

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN;

ARTICLE; AUTOMATION; BIOASSAY; CANCER CLASSIFICATION; CANCER STAGING; CLASSIFICATION ALGORITHM; DISEASE MARKER; HIGH RISK PATIENT; HISTOPATHOLOGY; LARGE CELL CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA; LOGISTIC REGRESSION ANALYSIS; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG NODULE; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ALPHA 1-ANTITRYPSIN; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CARCINOEMBRYONIC ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOGISTIC MODELS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SERPINS; SOLITARY PULMONARY NODULE;

EID: 84882570856     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201210-1760OC     Document Type: Article

References (20)

1. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, Patz EF Jr, Swensen SJ. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400.
2. Patz EF Jr, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon JE II. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 2007;25:5578-5583.
3. Midthun DE, Swensen SJ, Jett JR, Hartman TE. Evaluation of nodules detected by screening for lung cancer with low dose spiral computed tomography. Lung Cancer 2003;41:S40.
4. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lungcancer mortality with low-dose computed tomographic screening.NEngl J Med 2011;365:395-409.
5. Breiman L. Classification and regression trees. Belmont, CA: Wadsworth International Group; 1984.
6. Steinberg D, Golovnya M, Tolliver D. Cart for windows user guide. San Diego, CA: Salford Systems; 2002.
7. Brandman S, Ko JP. Pulmonary nodule detection, characterization, and management with multidetector computed tomography. J Thorac Imaging 2011;26:90-105.
8. Weir G, Kos S, Burrill J, Salat P, Ho S, Liu D. Diagnosis and management of the solitary pulmonary nodule. BMJ 2011;343:d4866.
9. Goo JM, Park CM, Lee HJ. Ground-glass nodules on chest CT as imaging biomarkers in the management of lung adenocarcinoma. AJR Am J Roentgenol 2011;196:533-543.
10. Kim HK, Choi YS, Kim J, Shim YM, Lee KS, Kim K. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol 2010;5:206-210.
11. Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology 2007;245:267-275.
12. Lee HY, Lee KS. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. J Thorac Imaging 2011;26:106- 118.
13. Erasmus JJ, Patz EF Jr. Positron emission tomography imaging in the thorax. Clin Chest Med 1999;20:715-724.
14. Patz EF, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, Goodman PC. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyflucose pet scanning. Radiology 1993;188:487-490.
15. Baker SG. Gene signatures revisited. J Natl Cancer Inst 2012;104:262- 263.
16. Hand D. Classifier technology and the illusion of progress. Stat Sci 2006; 21:1-14.
17. Midthun DE, Swensen SJ, Jett Jr. Clinical strategies for solitary pulmonary nodule. Annu Rev Med 1992;43:195-208.
18. Aloia T, Bepler G, Harpole D, Goodman PC, McAdams HP, Erasmus JJ, Herndon JE, Patz EF Jr. Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities. Cancer Detect Prev 2001;25:336-343.
19. Patz EF Jr. Integration of biomarkers and imaging. J Thorac Oncol 2006; 1:78-80.
20. Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, Siegfried JM. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol 2012;7:698-708.